Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.87 |
| ▸ | PAM | P19021 | 2/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.57 |
| ▸ | PPARG | P37231 | 7/20 | 0.57 |
| ▸ | PPARD | Q03181 | 7/20 | 0.57 |
| ▸ | PPARA | Q07869 | 7/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Allyl Octadecanoate SCHEMBL28396519 | 1.00 | TSHR (0.87) | TSHRPAMGPR84PPARGPPARD | |
| Allyl Heptanoate SCHEMBL28325536 | 1.00 | TSHR (0.87) | TSHRPAMGPR84PPARGPPARD | |
| Dodecanoate SCHEMBL28078900 | 1.00 | TSHR (0.87) | TSHRPAMGPR84PPARGPPARD | |
| Allyl Hexanoate SCHEMBL7023588 | 0.98 | TSHR (0.83) | TSHRPAMGPR84PPARGPPARD | |
| Allyl Octadecanoate SCHEMBL21611732 | 0.93 | TSHR (0.87) | TSHRPAMGPR84PPARGPPARD | |
| Allyl Heptanoate SCHEMBL20820 | 0.93 | TSHR (1.00) | TSHRPAMALDH1A1KMT2AMEN1 | |
| Allyl Heptanoate SCHEMBL4147097 | 0.93 | TSHR (1.00) | TSHRPAMALDH1A1KMT2AMEN1 | |
| SCHEMBL440501 | 0.93 | TSHR (1.00) | TSHRPAMALDH1A1KMT2AMEN1 | |
| Allyl Octanoate SCHEMBL126629 | 0.93 | TSHR (1.00) | TSHRPAMALDH1A1KMT2AMEN1 | |
| SCHEMBL3503097 | 0.93 | TSHR (1.00) | TSHRPAMALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10555878-B2 | Solid antiperspirant and/or deodorant composition in the form of a water-in-oil emulsion based on silicone emulsifiers and on waxes; method for treating body odours | L'OREAL (FR) | 2020-02-11 | — | — | US | disclosed |
| EP-2221039-B1 | Antiperspirant compositions | UNILEVER PLC NO 41424 (GB) | 2017-11-22 | — | — | EP | disclosed |
| EP-2340009-B1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER PLC (GB) | 2017-04-19 | — | — | EP | disclosed |
| EP-2181691-B1 | Antiperspirant compositions | UNILEVER PLC (GB) | 2016-12-21 | — | — | EP | disclosed |
| EP-2181692-B1 | Antiperspirant compositions | UNILEVER PLC (GB) | 2016-09-28 | — | — | EP | disclosed |
| EP-2229135-B1 | SOLID ANTIPERSPIRANT AND/OR DEODORANT COMPOSITION IN THE FORM OF A WATER-IN-OIL EMULSION BASED ON SILICONE EMULSIFIERS AND ON WAXES; METHOD FOR TREATING BODY ODOURS | ORÉAL L (FR) | 2015-12-02 | — | — | EP | disclosed |
| US-9095531-B2 | Antiperspirant compositions | CONOPCO, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-9060957-B2 | — | — | 2015-06-23 | — | — | US | disclosed |
| US-20140193471-A1 | SOLID ANTIPERSPIRANT AND/OR DEODORANT COMPOSITION IN THE FORM OF A WATER-IN-OIL EMULSION BASED ON SILICONE EMULSIFIERS AND ON WAXES; METHOD FOR TREATING BODY ODOURS | L'OREAL (FR) | 2014-07-10 | — | — | US | disclosed |
| US-8673327-B2 | Solid antiperspirant and/or deodorant composition in the form of a water-in-oil emulsion based on silicone emulsifiers and on waxes; method for treating body odours | L'OREAL (FR) | 2014-03-18 | — | — | US | disclosed |
| EP-1280502-B1 | COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 2005-08-24 | — | — | EP | disclosed |
| EP-1304999-A1 | ANTIPERSPIRANT FORMULATIONS | UNILEVER PLC (GB) | 2003-05-02 | — | — | EP | disclosed |
| US-20020039563-A1 | Antiperspirant formulations | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC | 2002-04-04 | — | — | US | disclosed |
| US-6361765-B1 | COMPOSITION COMPRISING PARTICULATE ANTIPERSPIRANT ACTIVE, ANHYDROUS LIQUID CARRIER AND STRUCTURANT OR THICKNENER COMPRISING ORGANIC WAX HAVING SPECIFIED MELTING POINT, AT LEAST 60% OF WHICH IS PROVIDED BY ALIPHATIC ESTER | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-03-26 | — | — | US | disclosed |
| US-6361766-B1 | ANHYDROUS FORMULATION COMPRISING PARTICULATE ANTIPERSPIRANT SUSPENDED IN WATER-IMMISCIBLE CARRIER FLUID COMPRISING OXYGEN-CONTAINING EMOLLIENT OIL HAVING SPECIFIED REFRACTIVE INDEX STRUCTURED BY WAX OR NONPOLYMERIC FIBER-FORMING GELLANT | UNILEVER HOME & PERSONAL CARE, USA DIVISION OF CONOPCO, INC. | 2002-03-26 | — | — | US | disclosed |
| US-20020034481-A1 | Antiperspirant formulations | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-03-21 | — | — | US | disclosed |
| EP-1180010-A1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER PLC (GB) | 2002-02-20 | — | — | EP | disclosed |
| WO-2002011692-A1 | ANTIPERSPIRANT FORMULATIONS | UNILEVER PLC (GB) | 2002-02-14 | — | — | WO | disclosed |
| WO-2002011691-A1 | ANTIPERSPIRANT FORMULATIONS | UNILEVER PLC (GB) | 2002-02-14 | — | — | WO | disclosed |
| WO-2000074640-A1 | ANTIPERSPIRANT COMPOSITIONS | UNILEVER PLC (GB) | 2000-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034481-A1 | Antiperspirant formulations | ADH1A, SOAT1, CUTA | TSHR 2742/4885PAM 2236/4885GPR84 1024/4885 |
| US-20140193471-A1 | SOLID ANTIPERSPIRANT AND/OR DEODORANT COMPOSITION IN THE FORM OF A WATER-IN-OIL EMULSION BASED ON SILICONE EMULSIFIERS AND ON WAXES; METHOD FOR TREATING BODY ODOURS | DGAT1, DGAT2, DDT | TSHR 2878/4885PAM 3373/4885GPR84 485/4885 |
| US-10555878-B2 | Solid antiperspirant and/or deodorant composition in the form of a water-in-oil emulsion based on silicone emulsifiers and on waxes; method for treating body odours | DGAT1, DGAT2, DDT | TSHR 2878/4885PAM 3373/4885GPR84 485/4885 |
| US-20020039563-A1 | Antiperspirant formulations | ADH1A, SOAT1, CUTA | TSHR 2794/4885PAM 1752/4885GPR84 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.